#Regulatory review

Articles (2)

• 🇺🇸 Moderna says FDA to review its flu vaccine after reversing course — 18/02/2026 [USA]

  With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

  Related: #Pharmaceutical development, #Seasonal influenza, #U.S. FDA policy, #Vaccine distribution
• 🇺🇸 U.S. FDA reverses course, will review Moderna's modified flu vaccine application — 18/02/2026 [USA]

  Moderna said on Wednesday the U.S. Food and ⁠Drug Administration has agreed to review its influenza vaccine application, reversing an ​earlier decision.

  Related: #Vaccine development, #Influenza vaccine, #U.S. public health policy